price
PH
NASDAQ · PHAT
Phathom Pharmaceuticals, Inc.
Healthcare · Biotechnology
$7.01
Up+$0.30 (+4.28%)
Updated Oct 21, 2026, 1:45 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.04B
- P/E ratio
- -3.89
- Dividend yield
- 0.00%
- 52-week range
- $6.52 – $18.31
- Volume
- 1.02M
- Avg. volume
- 1.06M
Price performance · PHAT
PHAT price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 19, 2026
PHAT closed at $7.01 after 20 trading sessions, down 9.66% for the selected period.
- Last close
- $7.01
- Period change
- -9.66%
- Period low
- $6.70
- Period high
- $7.76
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | $6.88 | $7.05 | $6.78 | $7.01 | 1.02M |
| Oct 16, 2026 | $7.51 | $7.5699 | $6.90 | $6.92 | 1.25M |
| Oct 15, 2026 | $7.54 | $7.69 | $7.41 | $7.50 | 1.21M |
| Oct 14, 2026 | $6.97 | $7.72 | $6.9178 | $7.40 | 1.72M |
| Oct 13, 2026 | $7.14 | $7.16 | $6.86 | $7.00 | 1.95M |
| Oct 12, 2026 | $7.25 | $7.285 | $7.03 | $7.13 | 1.01M |
| Oct 9, 2026 | $7.13 | $7.30 | $7.015 | $7.25 | 928.34K |
| Oct 8, 2026 | $6.79 | $7.18 | $6.68 | $7.13 | 1.33M |
| Oct 7, 2026 | $6.87 | $7.03 | $6.60 | $6.81 | 1.63M |
| Oct 6, 2026 | $6.75 | $6.80 | $6.52 | $6.78 | 2.09M |
| Oct 5, 2026 | $6.95 | $7.00 | $6.645 | $6.70 | 1.1M |
| Oct 2, 2026 | $7.20 | $7.23 | $6.82 | $6.92 | 1.68M |
| Oct 1, 2026 | $7.47 | $7.47 | $7.08 | $7.08 | 1.06M |
| Sep 30, 2026 | $7.40 | $7.50 | $7.19 | $7.30 | 809.2K |
| Sep 29, 2026 | $7.34 | $7.45 | $7.185 | $7.36 | 657.26K |
| Sep 28, 2026 | $7.30 | $7.41 | $7.15 | $7.35 | 1.69M |
| Sep 25, 2026 | $7.10 | $7.38 | $7.095 | $7.30 | 1.44M |
| Sep 24, 2026 | $6.98 | $7.19 | $6.91 | $7.08 | 1.42M |
| Sep 23, 2026 | $7.825 | $7.825 | $6.98 | $6.985 | 1.05M |
| Sep 22, 2026 | $7.58 | $7.84 | $7.40 | $7.76 | 1.95M |
Latest PHAT news
The latest Smart Investors Daily articles mentioning PHAT.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…

